Outcomes of COVID-19: The SECURE-IBD Registry

November 19, 2020

Watch the video below to get the latest recommendations for people affected by Crohn's or colitis, and learn about recent findings from the SECURE-IBD registry. The international pediatric and adult database monitors and reports on outcomes of COVID-19 in IBD patients.

Experts also provide updates on COVID-19 vaccines and what it means for people living with Crohn's or colitis. 

  • Panel Members

    Dr. Manasi Agrawal (MD), Instructor in Medicine in the Division of Gastroenterology at the Icahn School of Medicine at Mount Sinai, New York

    Dr. Erica Brenner (MD, MSc Candidate), Pediatric Gastroenterology Fellow, University of North Carolina at Chapel Hill


    Dr. Gilaad Kaplan (MD, MPH, FRCPC), Professor of Medicine, Gastroenterologist and Epidemiologist, Departments of Medicine and Community Health Sciences, University of Calgary, Past Chair of the Scientific and Medical Advisory Council, Crohn's and Colitis Canada

    Dr. Eric Benchimol (MD, PhD, FRCPC), Professor, Pediatric Gastroenterologist, Department of Paediatrics, The Hospital for Sick Children (SickKids) and University of Toronto, Division of Gastroenterology, Hepatology and Nutrition, SickKids, Chair of the Scientific and Medical Advisory Council, Crohn's and Colitis Canada

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.